跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 110 条关于
“LCA1”
全部
110
临床试验
61
药物
29
机构
0
资讯
20
2年前
Gene Therapy Shows Promise in Restoring Vision for LCA1 Patients
去年
Atsena Therapeutics and Nippon Shinyaku Partner to Advance Gene Therapy for LCA1
去年
Atsena Therapeutics Secures $150M Series C Funding to Advance Ocular Gene Therapies for Inherited Blindness
去年
FDA Approves Autolus' Obecabtagene Autoleucel (Aucatzyl) for R/R B-cell ALL
2年前
Atsena Therapeutics Reports Promising Results for XLRS Gene Therapy Using Novel Spreading Capsid
去年
Hubble Therapeutics Secures $7.3M Series A Funding for Gene Therapy Targeting Rare Childhood Blindness
6年前
First In Vivo CRISPR Therapy Dosed in Clinical Trial for Congenital Blindness
去年
Repurposed Blood Pressure Drug Shows Promise for Treating Inherited Retinal Diseases with Sex-Specific Benefits
7天前
Editas Medicine Targets 2026 Patient Dosing for In Vivo CRISPR LDL Therapy EDIT-401
去年
Opus Genetics to Present 6-Month Data on OPGx-LCA5 Gene Therapy for LCA5-Associated Inherited Retinal Disease
第 1 页,共 2 页
上一页
下一页